InVivo Therapeutics Holdings Corp. (NVIV) Soars 14.47% on November 05 – Equities.com

Market SummaryFollow

InVivo Therapeutics Holdings Corp. is a InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury.

NVIV - Market Data & News

NVIV - Stock Valuation Report

InVivo Therapeutics Holdings Corp. (NVIV) had a good day on the market for Tuesday November 05 as shares jumped 14.47% to close at $0.49. About 55,368 shares traded hands on 139 trades for the day, compared with an average daily volume of n/a shares out of a total float of 9.31 million. After opening the trading day at $0.47, shares of InVivo Therapeutics Holdings Corp. stayed within a range of $0.50 to $0.44.

With today's gains, InVivo Therapeutics Holdings Corp. now has a market cap of $4.58 million. Shares of InVivo Therapeutics Holdings Corp. have been trading within a range of $2.14 and $0.35 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.

InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.

InVivo Therapeutics Holdings Corp. is based out of Cambridge, MA and has some 6 employees. Its CEO is Richard M. Toselli.

For a complete fundamental analysis of InVivo Therapeutics Holdings Corp., check out Equities.coms Stock Valuation Analysis report for NVIV.

Still paying commissions on stock trades? Equities.com now offers $7.99/month unlimited trading and flat-fee options trading for $89.99/month! Get started today by https://www.equities.com/trading-start

InVivo Therapeutics Holdings Corp. is also a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

To get more information on InVivo Therapeutics Holdings Corp. and to follow the companys latest updates, you can visit the companys profile page here: NVIVs Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.coms Newsdesk. Also, dont forget to sign-up for our daily email newsletter to ensure you dont miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE:The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Go here to see the original:
InVivo Therapeutics Holdings Corp. (NVIV) Soars 14.47% on November 05 - Equities.com